Peter J Hand

Summary

Affiliation: Royal Melbourne Hospital
Country: Australia

Publications

  1. ncbi Interobserver agreement for the bedside clinical assessment of suspected stroke
    Peter J Hand
    Division of Clinical Neurosciences, Western General Hospital, Edinburgh, UK
    Stroke 37:776-80. 2006
  2. ncbi Distinguishing between stroke and mimic at the bedside: the brain attack study
    Peter J Hand
    Stroke Centre, Department of Neurology, Royal Melbourne Hospital, Monash University, Victoria, Australia
    Stroke 37:769-75. 2006
  3. ncbi Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial
    Stephen M Davis
    Department of Neurology, Royal Melbourne Hospital, University of Melbourne, Australia
    Lancet Neurol 7:299-309. 2008
  4. ncbi Persistent infarct hyperintensity on diffusion-weighted imaging late after stroke indicates heterogeneous, delayed, infarct evolution
    Carly S Rivers
    Division of Clinical Neurosciences, Western General Hospital, Edinburgh, UK
    Stroke 37:1418-23. 2006
  5. ncbi Acute hyperglycaemia and mortality in patients with transient ischaemic attack
    Matthew N T Thuy
    Department of Neurology, Royal Melbourne Hospital, Parkville, Victoria, Australia
    J Clin Neurosci 17:305-7. 2010
  6. ncbi Acute ischemic stroke lesion measurement on diffusion-weighted imaging--important considerations in designing acute stroke trials with magnetic resonance imaging
    Carly S Rivers
    Clinical Trials Research Unit, University of Leeds, Leeds, United Kingdom
    J Stroke Cerebrovasc Dis 16:64-70. 2007
  7. ncbi Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underused
    Stephen M Davis
    Med J Aust 187:548-9. 2007

Detail Information

Publications7

  1. ncbi Interobserver agreement for the bedside clinical assessment of suspected stroke
    Peter J Hand
    Division of Clinical Neurosciences, Western General Hospital, Edinburgh, UK
    Stroke 37:776-80. 2006
    ..We aimed to measure inter-rater reliability for the clinical assessment of stroke, with emphasis on items of history, timing of symptom onset, and diagnosis of stroke or mimic. We explored reasons for poor reliability...
  2. ncbi Distinguishing between stroke and mimic at the bedside: the brain attack study
    Peter J Hand
    Stroke Centre, Department of Neurology, Royal Melbourne Hospital, Monash University, Victoria, Australia
    Stroke 37:769-75. 2006
    ..We aimed to determine the frequency and nature of stroke mimics and to identify the key clinical features that distinguish between stroke and mimic at the bedside...
  3. ncbi Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial
    Stephen M Davis
    Department of Neurology, Royal Melbourne Hospital, University of Melbourne, Australia
    Lancet Neurol 7:299-309. 2008
    ..We aimed to test whether alteplase given 3-6 h after stroke onset promotes reperfusion and attenuates infarct growth in patients who have a mismatch in perfusion-weighted MRI (PWI) and diffusion-weighted MRI (DWI)...
  4. ncbi Persistent infarct hyperintensity on diffusion-weighted imaging late after stroke indicates heterogeneous, delayed, infarct evolution
    Carly S Rivers
    Division of Clinical Neurosciences, Western General Hospital, Edinburgh, UK
    Stroke 37:1418-23. 2006
    ..Further study is required to determine underlying mechanisms and any potential for subacute intervention to improve recovery...
  5. ncbi Acute hyperglycaemia and mortality in patients with transient ischaemic attack
    Matthew N T Thuy
    Department of Neurology, Royal Melbourne Hospital, Parkville, Victoria, Australia
    J Clin Neurosci 17:305-7. 2010
    ..g. ABCD and ABCD2). Multivariate analysis identified age, atrial fibrillation and duration 1 hour as independent significant predictors of mortality...
  6. ncbi Acute ischemic stroke lesion measurement on diffusion-weighted imaging--important considerations in designing acute stroke trials with magnetic resonance imaging
    Carly S Rivers
    Clinical Trials Research Unit, University of Leeds, Leeds, United Kingdom
    J Stroke Cerebrovasc Dis 16:64-70. 2007
    ..Little is known of what factors might affect DWI lesion size measurement. We examined morphologic factors that might affect DWI lesion measurement...
  7. ncbi Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underused
    Stephen M Davis
    Med J Aust 187:548-9. 2007
    ..Australian health systems must rise to the challenge of providing thrombolysis to more stroke patients...